The use of hydrogen peroxide as a medical drug

Rivista Italiana di Ossigeno-Ozonoterapia

Volumn 4, Issue 1, 2005, Pages 30-39

  Bocci, Velio ^a,b   Aldinucci, ^a   Bianchi, L ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b Arciconfraternita di Misericordia Medical Clinic   (Italy)

Author keywords

Hydrogen peroxide; LOPs; Macular degeneration; Oxidative stress; Ozone; ROS

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; CATALASE; GLUCOSE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; LIPID; OZONE; PROTEIN; REACTIVE OXYGEN METABOLITE; SODIUM NITRATE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; URIC ACID;

ARTICLE; CANCER CHEMOTHERAPY; DRUG METABOLISM; DRUG STABILITY; HUMAN; ISCHEMIA; LIPID OXIDATION; RETINA MACULA AGE RELATED DEGENERATION; SIDE EFFECT; TARGET CELL;

EID: 20044374863     PISSN: 17206561     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Schreck R, Rieber P, Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10: 2247-2258, 1991.
2. Angel P, Karin M: The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072: 129-157, 1991.
3. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 12: 2005-2015, 1993.
4. Burdon RH, Gill V, Rice-Evans C: Oxidative stress and tumour cell proliferation. Free Radic. Res. Commun 11: 65-76, 1990.
5. Yasuda M, Ohzeki Y, Shimizu S et Al: Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. Life Sci 64: 249-258, 1999.
6. 2 in rat heart endothelial cells. Free Radic. Biol. Med 25: 891-897, 1998.
7. Reth M: Hydrogen peroxide as second messenger in lymphocyte activation. Nat.Immunol 3: 1129-1134, 2002.
8. Bocci V, Valacchi G, Corradeschi F et Al: Studies on the biological effects of ozone: 8. Effects on the total antioxidant status and on interleukin-8 production. Mediators. Inflamm 7: 313-317, 1998.
9. DeForge LE, Fantone JC, Kenney JS et Al: Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood. J.Clin.Invest 90: 2123-2129, 1992.
10. Shono T, Ono M, Izumi H et Al: Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol.Cell Biol 16: 4231-4239, 1996.
11. Sundaresan M, Yu ZX, Ferrans VJ et Al: Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
12. May JM, de Haen C: Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal fat cells. J.Biol.Chem 254: 2214-2220, 1979.
13. Woo CH, You HJ, Cho SH et Al: Leukotriene B(4) stimulates Rac-ERK cascade to generate reactive oxygen species that mediates chemotaxis. J.Biol.Chem 277, 8572-8578, 2002.
14. Rhee SC, Bae YS, Lee SR et Al: Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci. STKE: 2000, E1.
15. Bocci V: Oxygen-ozone therapy. A critical evaluation. 1-440, Kluwer Academic Publishers, Dordrecht, The Netherlands, 2002.
16. Bocci V: Ozone. A new medical drug. Springer, Dordrecht, The Netherlands: 2004, 1-295.
17. Valacchi G, Bocci V: Studies on the biological effects of ozone: 11. Release of factors from human endothelial cells. Mediators.Inflamm 9: 271-276, 2000.
18. Brown MR, Miller FJ Jr., Li WG et Al: Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells. Circ.Res 85: 524-533, 1999.
19. Thengchaisri N, Kuo L:Hydrogen peroxide induces endothelium-dependent and -independent coronary arteriolar dilation: role of cyclooxygenase and potassium channels. Am. J. Physiol Heart Circ. Physiol 285: H2255-H2263, 2003.
20. 2 gradients across biomembranes. FEBS Lett 475: 121-126, 2000.
21. Stone JR, Collins T: The role of hydrogen peroxide in endothelial proliferative responses. Endothelium, 9, 231-238.
22. I. N. Love (1888) Peroxide of hydrogen as a remedial agent. JAMA 2002: 262-265.
23. Badwey JA, Karnovsky ML: Active oxygen species and the functions of phagocytic leukocytes. Annu. Rev. Biochem 49: 695-726, 1980.
24. Farr CH: Protocol for the intravenous administration of hydrogen peroxide. International Bio-Oxidative Medicine Foundation, Oklahoma City 1993: 29-31.
25. Urschel HC: Cardiovascular effects of hydrogen peroxide: current status. Dis. Chest 51: 180-192, 1967.
26. Sasaki H, Wakutani T, Oda S et Al: Application of hydrogen peroxide infusion to maxillary cancer. Yonago. Acta Med 11: 141-149, 1967.
27. Nathan CF, Cohn ZA: Antitumor effects of hydrogen peroxide in vivo. Journal of Experimental Medicine 154, 1539-1553, 1981.
28. Symons MC, Rusakiewicz S, Rees RC et Al: Hydrogen peroxide: a potent cytotoxic agent effective in causing cellular damage and used in the possible treatment for certain tumours. Medical Hypotheses 57: 56-58, 2001.
29. Green MJ, Hill HAO: Chemistry of dioxygen. Methods in Enzimology 105: 3-22, 1984.
30. Rice-Evans C, Miller NJ: Total antioxidant status in plasma and body fluids. Methods Enzymol 234. 279-293, 1994.
31. Buege JA, Aust SD: Microsomal lipid peroxidation. Methods in Enzimology 233: 302-310, 1994.
32. Hu M-L: Measurement of protein thiol groups and glutathione in plasma. Methods in Enzimology 233: 380-385, 1994.
33. Bocci V: Does ozone therapy normalize the cellular redox balance? Medical Hypotheses 46: 150-154, 1996.
34. Bocci V, Valacchi G, Rossi R et Al: Studies on the biological effects of ozone: 9. Effects of ozone on human platelets. Platelets 10: 110-116, 1999.
35. Valacchi G, Bocci V: Studies on the biological effects of ozone: 10. Release of factors from ozonated human platelets. Mediators of Inflammation 8: 205-209, 1999.
36. Dianzani MU: 4-Hydroxynonenal and cell signalling. Free Rad.Res 28: 553-560, 1998.
37. León OS, Menéndez S, Merino N et Al: Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Mediators of Inflammation 7: 289-294, 1998.
38. Barber E, Menéndez S, León OS: Prevention of renal injury after induction of ozone tolerance in rats submitted to warm ischaemia. Mediators of Inflammation 8: 37-41, 1999.